Perineural Therapy Market Players:
- Boston Scientific Corporation
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- tVNS Technologies GmbH
- Abbott Laboratories
- NeuroSigma, Inc.
- Axogen Corporation
- BioWave Limited
- Baxter Healthcare Corporation
- LivaNova, PLC
- Integra LifeSciences Corporation
- Soterix Medical, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of perineural therapy is assessed at USD 509.72 million.
The global perineural therapy market size was valued at over USD 448.03 million in 2025 and is expected to expand at a CAGR of around 15.3%, surpassing USD 1.86 billion revenue by 2035.
North America perineural therapy market is projected to command the largest revenue share by 2035, driven by the high prevalence of sports injuries and increasing adoption of advanced nerve repair technologies.
Key players in the market include Merck & Co. Inc., Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., GSK plc, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Eli Lilli and Company.
